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RESEARCH NOTE BACTERIOLOGYPrevalence of phylogroups and O25/ST131
in susceptible and extended-spectrum
β-lactamase-producing Escherichia coli
isolates, the NetherlandsI. T. M. A. Overdevest1,2, A. M. C. Bergmans1,3, J. J. Verweij2,
J. Vissers1, N. Bax1, E. Snelders1 and J. A. J. W. Kluytmans1,2,4
1) Laboratory for Microbiology and Infection Control, Amphia Hospital,
Breda, 2) Laboratory for Medical Microbiology and Immunology, St. Elisabeth
Hospital, Tilburg, 3) Laboratory for Medical Microbiology, Franciscus Hospital,
Roosendaal and 4) Julius Centre, University Medical Centre, Utrecht,
The NetherlandsAbstractTo assess the distribution of phylogroups and O25/ST131 in the
Netherlands, we performed a real-time polymerase chain reaction
(PCR) on a collection of 108 wild-type Escherichia coli (WT-EC)
and 134 extended-spectrum β-lactamase–producing E. coli (ESBL-
EC). Phylogroup B2 was predominant, but ESBL-EC were less
likely to belong to this phylogroup (48.5%) than were WT-EC
(66.7%; p = 0.005). In WT-EC, phylogroups B2 and D seem to be
more virulent, having a higher prevalence among midstream urine
isolates and blood culture isolates, than in catheter-related urine
isolates (83.3% and 87.9% vs. 61.9%; p 0.048). O25/ST131 is
associated with ESBL production, being almost absent among
phylogroup B2 WT-EC (61.5% vs. 5.6%; p < 0.001).
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p://dx.doi.org/10.1016/j.cmi.2015.02.020IntroductionEscherichia coli is an important cause of urinary tract infections
and systemic infections in humans [1]. The primary reservoir
for infections due to E. coli is the patient’s own intestinal tract
[2]. Factors associated with increased risk of infection are pa-
tient- and pathogen dependent. Patient-dependent factors
include underlying illnesses, female sex, the use of indwelling
catheters, and previous antimicrobial use [3]. Pathogen-
dependent factors include differences in virulence between
phylogenetic group A, B1, B2 and D [4] E. coli. Isolates belonging
to phylogroup B2 or D are often extraintestinal pathogenic
E. coli (ExPEC), causing urinary tract infections and systemic
infections [5,6].
Antimicrobial resistance due to production of extended-
spectrum β-lactamases in E. coli (ESBL-EC) is increasing [7,8].
One subgroup within the ESBL-EC B2 phylogroup, O25/ST131
E. coli, has successfully spread worldwide [9] and in the com-
munity [10].Materials and methodsIn this study we determined the distribution of phylogroups A,
B1, B2, and D, and the prevalence of O25/ST131 in the
Netherlands, within a collection of ESBL-EC obtained from
rectal colonisation samples, and ESBL-EC and wild-type E. coli
(WT-EC) obtained from urine and blood cultures. All isolates
were collected in our laboratory for medical microbiology,
situated in a large teaching hospital in the southern part of the
Netherlands. The rectal colonisation samples were obtained
from hospitalized patients during routine cross-sectional sur-
veys in November 2012 and 2013. ESBL-EC obtained from
urine samples are routinely stored at -80°C, and retrospec-
tively collected between January 2010 and March 2013. A
comparable number of WT-EC isolates were collected pro-
spectively between February and August 2013. Isolates ob-
tained from blood cultures are routinely stored at -80°C, and
all available ESBL-EC obtained from unique patients were
retrospectively collected between January 2010 and March
2013. For every ESBL-EC, the next available WT-EC isolate was
included.
Phylogenetic typing was performed on all E. coli isolates using
real-time polymerase chain reaction (PCR) [11], and an O25/
ST131 speciﬁc real-time PCR was performed on all phylogroup
B2 E. coli isolates [12]. Sequence analysis was performed on
isolates with inconclusive results in the O25/ST131-speciﬁcious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Overdevest et al. Prevalence of phylogroups and O25/ST131 E. coli 570.e2real-time PCR to detect the pathognomonic A and T single
nucleotide polymorphism in the pabB gene.
Differences in the prevalence of phylogroups and O25/
ST131 were analysed with χ2 analysis using the Statistical
Package for Social Sciences software (SPSS, version 17). Sta-
tistical signiﬁcance was accepted if the chance for coincidence
was <5%.ResultsA total of 242 E. coli isolates were included in the study. All
blood culture isolates, all rectal swab isolates, and all but one of
the catheter-related urine isolates (95.2% of WT-EC and 100%
of ESBL-EC) were obtained from hospitalised patients, whereas
the majority of midstream urine isolates was obtained from
general practitioners’ patients (40 WT-EC; 74.1% and 34 ESBL-
EC; 79.1%). Table 1 shows the age and sex distribution of pa-
tients with E. coli from the different origins, with patients for
whom a midstream isolate was included being more often fe-
male and signiﬁcantly younger than the other patients.
The majority of isolates belonged to phylogroup B2 (56.6%;
Fig. 1), and this was the predominant phylogroup in all sub-
categories. ESBL-EC isolates were less likely to belong to this
phylogroup (48.5%) compared with WT-EC (66.7%, p 0.005;
49.0% vs. 66.7% and p 0.010 when excluding the rectal swab
isolates from the analysis). The majority of the B2 phylogroup
ESBL-EC isolates belonged to clonal complex O25/ST131
(61.5%) vs. a small minority of the B2 phylogroup WT-EC
(5.6%; p < 0.001). The prevalence of O25/ST131 in ESBL-EC
was lowest in the rectal colonization isolates (18.4%) vs.
37.2%, 36.8% and 29.4% for midstream urine isolates, catheter
related urine isolates and blood culture isolates, respectively.
However, these differences were not statistically different
(p 0.27).TABLE 1. Distribution of sex and age
WT-EC
Age
Mean (95% CI)
Rectal colonisation
Urine culture, midstream* 47.4 (40.3–54.4)
Urine culture, indwelling catheter† 73.3 (66.4–80.2)
Blood culture 67.6 (62.0–73.1)
Mean age with 95% conﬁdence interval and percentage of male subject among wild-type Esc
(ESBL-EC) isolates.
*Patients with positive midstream urine cultures (both ESBL-EC and WT-EC) were signiﬁca
(p < 0.001 and p < 0.001), and were signiﬁcantly more often female than the patients from
†Patients with indwelling catheters were signiﬁcantly older than patients with ESBL-EC in th
respectively).
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InSigniﬁcant differences in occurrence of phylogroup A, B1
and D between ESBL-EC and WT-EC were only present for
phylogroup A, with this phylogroup being more present in
ESBL-EC than in WT-EC obtained from blood cultures (26.5%
vs 6.1%; p 0.024).
For WT-EC, phylogroups B2 and D were more prevalent in
midstream urine isolates and in blood culture isolates than in
catheter-related urine culture isolates (83.3% and 87.9% vs.
61.9%; p 0.048). The prevalence of other phylogroups was
comparable between the groups of isolates.DiscussionIn the present study, remarkable differences were found be-
tween the prevalence of phylogroups and O25/ST131 in ESBL-
EC and WT-EC from different origins. Most striking is the
difference in prevalence of O25/ST131, being the most preva-
lent clone in ESBL-EC, and being almost absent in WT-EC. This
ﬁnding supports the idea that O25/ST131 owes its success to
the ESBL phenotype. Among WT-EC, phylogroups A and B1
were found to be less prevalent among midstream urine isolates
and human blood culture isolates as compared with WT-EC
obtained from catheter-related urine isolates. This ﬁnding
supports the hypothesis that these phylogroup isolates need
devices like catheters to overcome barriers to cause infection.
This phenomenon was not observed in ESBL-EC.
Our results regarding the predominance of phylogroup B2
and O25/ST131 in ESBL-EC are in line with the results of
Johnson et al. [13]. Furthermore, the ﬁndings regarding the
higher prevalence of phylogroup A in ESBL-EC than in WT-EC
are comparable. The main limitation of our study is the fact that
an O25/ST131-speciﬁc real-time PCR was used. Although O25/
ST131 constitutes the majority of ST131 isolates, O16 is
another serotype associated with ST131 status [14,15].ESBL-EC
Sex Age Sex
Male (%) Mean (95% CI) Male (%)
55.8 (46.4–65.3) 57.9
14.8 56.8 (48.2–65.4) 25.6
47.6 80.3 (76.2–84.3) 52.6
48.5 66.4 (60.3–72.5) 58.8
herichia coli (WT-EC) isolates and extended-spectrum β-lactamase–producing E.coli
ntly younger than patients with indwelling catheters or with positive blood cultures
whom other cultures were obtained (p 0.001 for WT-EC and p 0.008 for ESBL-EC).
eir rectal swabs or E. coli in their midstream urine cultures (p 0.001 and p < 0.001,
fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 570.e1–570.e4
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FIG. 1. Distribution of phylogroups
and O25/ST131.
570.e3 Clinical Microbiology and Infection, Volume 21 Number 6, June 2015 CMIIn conclusion, our study supports the idea that E. coli colo-
nizing the gut are not equally capable of causing infection. For
WT-EC, phylogroups B2 and D are more likely to cause
infection, whereas other phylogroups need devices such as
urinary catheters to overcome barriers and cause infection.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectFurthermore, our results show a signiﬁcant association of O25/
ST131 with ESBL production, with this strain being almost
absent in WT-EC isolates. Overall, phylogroup B2 is less
frequently seen in ESBL-EC than in WT-EC, whereas for phy-
logroup A the opposite was found.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 570.e1–570.e4
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